Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Scientific Reports|May 10, 2014
Transcriptional repressor domain of MBD1 is intrinsically disordered and interacts with its binding partners in a selective mannerUmar Farook Shahul Hameed, Jackwee Lim, Qian Zhang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 20, 2005
Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3Michal Marzec, Monika Kasprzycka, Andrzej Ptasznik, et al.
Cancer Research|September 6, 2005
Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serumPawel Wlodarski, Monika Kasprzycka, Xiaobin Liu, et al.
Cancer Research|April 19, 2006
Id1 transcription inhibitor-matrix metalloproteinase 9 axis enhances invasiveness of the breakpoint cluster region/abelson tyrosine kinase-transformed leukemia cellsMargaret Nieborowska-Skorska, Grazyna Hoser, Lori Rink, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 2006
Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disordersMouna El-Salem, Puthiyaveettil N Raghunath, Michal Marzec, et al.
The American Journal of Pathology|July 18, 2009
Activation of mTORC1 signaling pathway in AIDS-related lymphomasMouna El-Salem, Puthiyaveettil N Raghunath, Michal Marzec, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
Peroxisome proliferator-activated receptor gamma promotes lymphocyte survival through its actions on cellular metabolic activitiesSeung-Hee Jo, Chunyan Yang, Qi Miao, et al.
Transplantation|June 5, 2003
Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting dosesMiroslaw Majewski, Magdalena Korecka, Joanne Joergensen, et al.
Leukemia & Lymphoma|June 24, 2008
Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphomaElisabetta Capriotti, Eric C Vonderheid, Christopher J Thoburn, et al.
Cytokine|January 25, 2003
SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cellsJohannes Lundin Brockdorff, Anders Woetmann, Tomas Mustelin, et al.
Pageof 12